TrialJAMA2018
Effect of High-Flow Nasal Oxygen vs Standard Oxygen on 28-Day Mortality in Immunocompromised Patients With Acute Respiratory Failure: The HIGH Randomized Clinical Trial.
Elie Azoulay et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
149 papers cite itlatest 60 shown
this paperpooled ittrialcites it